Kennedy David P's Form 4 filing
1Life Healthcare Inc (ONEM) · filed Jul 19, 2021
- Accession no.
- 0001562180-21-005005
- Filed
- Jul 19, 2021
- Trade date
- Jul 15-19, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $73.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kennedy David PCIK 0001800529 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2021 | Common Stock | AGrant or awardAcquired | +382 | $0.00 | $0 | 382 | Direct | |
| Jul 19, 2021 | Common Stock | SSaleDisposed | −900 | $25.94F3 | −$23,346 | 258,213 | Indirect | |
| Jul 19, 2021 | Common Stock | SSaleDisposed | −1,878 | $26.75F5 | −$50,236.5 | 256,335 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
This transaction was executed in multiple trades at prices ranging from $25.46 to $26.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $26.46 to $27.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.